TY - JOUR
T1 - Cytokines and biological markers in autoimmune GFAP astrocytopathy
T2 - The potential role for pathogenesis and therapeutic implications
AU - Kimura, Akio
AU - Takemura, Masao
AU - Yamamoto, Yasuko
AU - Hayashi, Yuichi
AU - Saito, Kuniaki
AU - Shimohata, Takayoshi
N1 - Publisher Copyright:
© 2019 Elsevier B.V.
PY - 2019/9/15
Y1 - 2019/9/15
N2 - Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy (GFAP-A) is a corticosteroid-responsive meningoencephalomyelitis with a poorly understood pathogenesis. We examined and compared the levels of cytokines and biological markers in the cerebrospinal fluid (CSF) of patients with GFAP-A and other neurological disorders. We identified four cytokines (tumor necrosis factor alpha [TNFα], Interleukin [IL]-27, IL-6, and chemokine [C-C motif] ligand 20) and three biological markers (GFAP, S100 calcium-binding protein B, and neurofilament light chain) present at elevated levels in CSF samples during the acute phase of GFAP-A. Additionally, we identified significant correlations between CSF TNFα, IL-27, IL-6, and CSF biological markers.
AB - Autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy (GFAP-A) is a corticosteroid-responsive meningoencephalomyelitis with a poorly understood pathogenesis. We examined and compared the levels of cytokines and biological markers in the cerebrospinal fluid (CSF) of patients with GFAP-A and other neurological disorders. We identified four cytokines (tumor necrosis factor alpha [TNFα], Interleukin [IL]-27, IL-6, and chemokine [C-C motif] ligand 20) and three biological markers (GFAP, S100 calcium-binding protein B, and neurofilament light chain) present at elevated levels in CSF samples during the acute phase of GFAP-A. Additionally, we identified significant correlations between CSF TNFα, IL-27, IL-6, and CSF biological markers.
UR - http://www.scopus.com/inward/record.url?scp=85067884892&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067884892&partnerID=8YFLogxK
U2 - 10.1016/j.jneuroim.2019.576999
DO - 10.1016/j.jneuroim.2019.576999
M3 - Article
C2 - 31254929
AN - SCOPUS:85067884892
SN - 0165-5728
VL - 334
JO - Journal of Neuroimmunology
JF - Journal of Neuroimmunology
M1 - 576999
ER -